Abstract: A band seal having a strap including a head portion, a tail portion and a middle portion, a retainer, an adhesive pad and a release liner secured to the adhesive pad, wherein the band seal is positionable into three positions including a pre-attached position wherein the middle portion of the strap is in a non-looped orientation, a temporary position wherein the middle portion of the strap is in a looped orientation and the retainer holds the middle portion in this looped orientation with the tail portion being concentric with the middle portion, and an attached position wherein the release liner is removed from the adhesive pad and the tail portion is secured to the adhesive pad.

Abstract: This disclosure relates to an electronic tag that may be scanned using at least two modalities, such by scanning a radio-frequency identification (“RFID”) embedded within the tag and/or scanning a machine-readable label (“MRL”) visible from an outside of the tag. Systems may track and capture downstream user interaction with content presented in response to a scan. Systems may distinguish between scan of an MRL versus scans of an RFID chip. A scan of an MRL may trigger loading of a first scan destination on a scanning device. A scan of an RFID chip may trigger loading of a second scan destination on a scanning device. Systems may generate analytics on detected differences between whether an MRL or RFID chip is scanned.

Abstract: This disclosure relates to an electronic tag that may be scanned using at least two modalities, such by scanning a radio-frequency identification (“RFID”) embedded within the tag and/or scanning a machine-readable label (“MRL”) visible from an outside of the tag. Systems may track and capture downstream user interaction with content presented in response to a scan. Systems may distinguish between scan of an MRL versus scans of an RFID chip. A scan of an MRL may trigger loading of a first scan destination on a scanning device. A scan of an RFID chip may trigger loading of a second scan destination on a scanning device. Systems may generate analytics on detected differences between whether an MRL or RFID chip is scanned.

Abstract: The present invention provides cultivation chambers and methods for the cultivation of photosynthetic organisms, particularly algae.

Abstract: A liquid soluble protein drink comprised of whey protein concentrate or whey protein isolate in combination with egg lecithin which results in a protein supplement wherein the whey protein concentrate is 80% protein and the whey protein isolate is 90% protein when combined with egg lecithin and eliminating phytosterols.

Abstract: A whey protein crisp comprised of whey protein isolate, whey protein concentrate, and a binder, dry blended and mixed with water and introduced into an extruder which forms tubular whey protein strips which are cut to size and then dried. The protein crisp may optionally include a flavoring and/or a sweetener.

Abstract: The invention provides ways to determine the impact of diluting a solution wherein the diluting may be carried out for any of a variety of purposes. In one embodiment, the method enables accurate volume dispensation calculations independent of meniscus shape. In another embodiment, the method enables accurate determination of plate washing efficiency. In yet another embodiment, the method enables the accurate determination of dilution ratio over a plurality of dilution steps. The methods described may be carried out using one or more systems arranged to perform the steps. A kit of the invention includes instructions for carrying out the steps of the methods and, optionally, one or more solutions suitable for conducting photometric measurements.

Abstract: A method for precisely and accurately determining the volume of a test liquid aliquot which can be used to calibrate a liquid delivery device. The method is particularly useful for determining the volume of an aliquot of a test liquid which is complex or non-aqueous, or is both complex and non-aqueous. The test-stock mixture contains at least the test liquid and a stock solution including a first dye, the first dye having absorbance characteristics which are measurably distinguishable from the absorbance characteristics of a second dye. The test-stock mixture is mixed with a diluent including the second dye to form a sample solution to be used to measure absorbances of the first dye and the second dye. The volume of the test-stock mixture aliquot is calculated by using a formula based on the Beer-Lambert law which incorporates the measured absorbance values and a dilution characteristic of the test-stock mixture.

Abstract: A synthesis of fluoxetine is disclosed. The process begins with a lower alkyl ester of 3-benzoylpropionic acid, which is reduced in the presence of a chiral ligand to produce the corresponding .gamma.-hydroxy ester, and the ester is cleaved. The free acid is then condensed with the alcohol to form a .gamma.-lactone, which is treated with ammonia to provide the .gamma.-hydroxy amide. The amide undergoes a Hoffman rearrangement to provide a 2-oxo-1,3 oxazine, which is reduced to 3-(methylamino)-1-phenyl-1-propanol. The alcohol is deprotonated and reacted with a 4-chloro- or 4-fluoro benzotrifluoride to provide fluoxetine free base.

Abstract: A synthesis of fluoxetine is disclosed. The process begins with benzoylacetonitrile, which is reduced, optionally in the presence of a chiral ligand, to produce the corresponding aminoalcohol, and the amine is carbamoylated without isolation. The alcohol is deprotonated and reacted with 4-chloro- or 4-fluoro benzotrifluoride or with 4-trifluoromethylphenol to provide a carbamate of fluoxetine. The carbamate is reduced with a hydride or with borane to provide fluoxetine free base. The process may be employed for the synthesis of individual enantiomers of fluoxetine.

Abstract: A synthesis of fluoxetine is disclosed. The process begins with a lower alkyl ester of 3-benzoylpropionic acid, which is reduced in the presence of a chiral ligand to produce the corresponding .gamma.-hydroxy ester, and the ester is cleaved. The free acid is then condensed with the alcohol to form a .gamma.-lactone, which is treated with ammonia to provide the .gamma.-hydroxy amide. The amide undergoes a Hoffman rearrangement to provide a 2-oxo-1,3 oxazine, which is reduced to 3-(methylamino)-1-phenyl-1-propanol. The alcohol is deprotonated and reacted with a 4-chloro- or 4-fluoro benzotrifluoride to provide fluoxetine free base.